Global Direct-to-Consumer (DTC) Genetic Testing Market Growth Till, 2017 - 2022

Direct-to-Consumer (DTC) Genetic Testing market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Direct-to-Consumer (DTC) Genetic Testing in these regions, from 2012 to 2022 (forecast), covering
• North America
• Europe
• China
• Japan
• Southeast Asia
• India
Global Direct-to-Consumer (DTC) Genetic Testing market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
• 23andMe
• deCODEme
• DNA DTC
• GeneByGene
• Genecodebook Oy
• Genetrainer
• MD Revolution
• Myriad Genetics
• Navigenics
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
• Genome Data Bank Material Model
• Individual Health Planning Model
• Comprehensive Genome Tests Model
• Medical Precision Tests Model
• Restricted Trait Tests Model
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Direct-to-Consumer (DTC) Genetic Testing for each application, including
• Doctor Office
• Internet
• Others

Comments

Popular posts from this blog

Overview of the sexual wellness market in the US

Global commercial helicopter market may attain more than USD 11 billion in revenue by 2027

Hemodialysis And Peritoneal Dialysis Market is expected to expand at a CAGR of 6.61% from 2022 to 2030.